American Health Council Names Wolf H. Stapelfeldt, M.D. to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
38
American Health Council Names Wolf H. Stapelfeldt, M.D. to Education Board

NEW YORK, March 15, 2017 (GLOBE NEWSWIRE) -- Dr. Wolf H. Stapelfeldt, Professor and Department Chairman at St. Louis University, has been selected to join the Education Board at the American Health Council. He will be sharing his knowledge and expertise on Anesthesiology and Organ Transplantation.

In his current capacity as Tenured Professor and Department Chairman at St. Louis University since 2014, his day-to-day responsibilities include the oversight of the Anesthesia Department, researching and improving clinical outcomes while providing anesthesia services with an emphasis on minimizing harmful intraoperative hypotensive exposures. Dr. Stapelfeldt has authored over eighty-five academic research contributions with his research focused on liver transplantation and on creating predictive models, as well as developing electronic systems to allow physicians make better and more informed clinical decisions in real time at the various points of perioperative patient care.

He served as one of the Founders and as the original Chief Medical Officer of Talis Clinical, LLC, a Cleveland Clinic spinoff information management company. Talis Clinical has created software that distills and analyzes patient information in real time to guide physicians in the high stress high acuity care environments of the ORs, PACUs and ICUs. 

Following graduation with his medical degree summa cum laude from the University of Ulm School of Medicine in Germany in 1983, Dr. Stapelfeldt pursued a post-graduate residency in internal medicine at Klinikum Rechts der Isar in Munich, and a fellowship in physiology and a residency in anesthesiology at the Mayo Clinic in Rochester, Minnesota.

Prior to his role as Professor and Department Chairman at St. Louis University, Dr. Stapelfeldt has held a series of leadership positions and appointments including those of Chairman of the Department of General Anesthesiology at the Cleveland Clinic, Professor and Chairman of the Department of Anesthesiology at the University of Florida College of Medicine, Vice Chairman for Education at Mayo Clinic’s Department of Anesthesiology in Florida, Director of Liver Transplant Anesthesiology and Director of Research for the Anesthesia Service at the VA Medical Center in Pittsburgh and Assistant Professor of Anesthesiology at the University of Pittsburgh Medical Center (UPMC). Additionally, he served as the Assistant Professor of Anesthesiology and Physiology at Mayo Clinic in Rochester, Minnesota.

As a testament to his success, Dr. Stapelfeldt’s contributions over the course of his career have been recognized with a ‘Top Ten in Medicine’ Innovations Award at the Cleveland Clinic, a U.S. Department of Veterans Affairs Merit Review award, a Young Investigator Award from the Foundation for Anesthesia Education and Research (FAER) and Roche Laboratories as well as Resident of the Year and Edward C. Kendall Awards from the Mayo Clinic.

Garnering over three decades of medical expertise, Dr. Stapelfeldt owns several patents and trademarks related to Clinical Decision Support technologies and is the creator of the SLUScore™ perioperative risk scoring concept. Additionally, he has provided seminal assistance in the establishment of liver transplant anesthesia programs at the Mayo Clinics in Jacksonville, Florida, and in Phoenix/Scottsdale, Arizona, as well as at the Children’s’ Hospital in San José, Costa Rica.

Looking back, Dr. Stapelfeldt attributes his success to being a part of great health care organizations and working in wonderful departments. His desire to pursue a career in Anesthesiology developed from his love for real time physiology and pharmacology.

To further his professional development, Dr. Stapelfeldt maintains memberships with the American Society of Anesthesiologists (ASA), the International Anesthesia Research Society (IARS), and the Healthcare Information and Management Systems Society (HIMSS).

As a certified single-engine pilot, Dr. Stapelfeldt enjoys flying sport planes in his free time. Other activities include his active engagement in animal rescue.

Considering the future, Dr. Stapelfeldt hopes and strives for the widespread realization of a substantial reduction in the significant postoperative morbidity and mortality that commonly ensues in the days, weeks and months following surgery and anesthesia. 

For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: media@americanhealthcouncil.org

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WIN Expands Global Family Support to 124 Countries

Updated Category News Views 55

WIN's Ambitious Global Expansion In the ever-twisting labyrinth of corporate benefits, WIN is stepping up its game. We're talking an expansion that balloons past traditional fertility offerings into a global medley of support services covering every conceivable family and health scenario. It ain’t just about making babies anymore. When you're dealing with 124 countries,...

Continue Reading
Protalix Unveils Promising Gout Therapy Data at ACR 2026

Updated Category News Views 31

A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 202

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
EICMA 2026: Groundbreaking Moves in Two-Wheel World

Updated Category News Views 71

Revving Up in Milan: A Record-Breaking EICMA If you're into two-wheelers as much as stocks, EICMA 2026 is where all the action is happening. They opened the door with a bang at Fiera Milano Rho, pulling off their biggest showcase yet. Ten halls packed to the brim, up from nine the previous year, creating buzz across the globe. Showcasing 765 exhibitors and 2,142 brands...

Continue Reading
New Leadership at Reactive Tech: Claudio Facchin Steps In

Updated Category News Views 154

Facchin Joins Reactive Technologies: Power Play or Predictable Move? Let me tell you, the energy sector ain’t for the faint-hearted—especially when you’re talking grid stability. Reactive Technologies just tossed an ace on the table, appointing Claudio Facchin as the new Board Chairman. If you've been around the block, you might recognize Facchin's name from his...

Continue Reading
Leatt Gears Up for Q3 Results Conference Call

Updated Category News Views 106

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Continue Reading
Target Hospitality's Growth and Earnings Analysis Q3 2026

Updated Category News Views 64

Strategic Transformation: A Mixed Bag of Results In the raucous world of high-stakes business, folks, Target Hospitality Corp. (NASDAQ: TH) is making quite the noise. For Q3 2026, they trumpeted a juicy $129.1 million in revenue, which is a solid notch up by 30% from a year before. Yet, like a seasoned trader facing a knife-edge call, they're handling a bittersweet...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 47

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 132

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 55

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

How Xylem Stock Performance Over a Decade Benefits Investors

Updated Category News Views 217

Understanding Xylem's Remarkable Growth Xylem (NYSE: XYL) has demonstrated exceptional performance in the stock market over the past decade, outperforming broader market benchmarks. With an average annualized return of 15.4%, investors have seen a noteworthy increase in their investments. As it stands, Xylem's market capitalization is an impressive $37.30 billion,...

Continue Reading
Understanding Recent Riksbank Bond Auction Results Thoroughly

Updated Category News Views 240

Insights into the Latest Riksbank Auctions The recent Riksbank auctions have revealed critical information about government bonds that is vital for investors and stakeholders. This report discusses two bond auctions held on the same date, providing details on loans, yields, and bid volumes, shedding light on the auction outcomes. First Auction Overview The first auction...

Continue Reading
SR Bancorp Announces New Quarterly Cash Dividend of $0.05

Updated Category News Views 127

SR Bancorp Declares Quarterly Cash Dividend SR Bancorp, Inc. (NASDAQ: SRBK), the parent company of Somerset Regal Bank, has made a notable announcement regarding its quarterly dividend. The Board of Directors has approved a cash dividend payment of $0.05 per share. This decision reflects the company's solid financial performance and commitment to rewarding its...

Continue Reading
Topgolf Callaway Brands Collaborates with Golf Saudi for Growth

Updated Category News Views 73

Topgolf Callaway Brands Begins Expansion in the Middle East Topgolf Callaway Brands Corp is in the spotlight as it takes a significant step toward expanding in the Middle East. The company recently signed a strategic agreement with Golf Saudi to bring its diverse range of brands to the region. This partnership highlights Topgolf Callaway's commitment to enhancing the...

Continue Reading
Transforming Packaging: PolyCycle's Innovations and Sustainability Focus

Updated Category News Views 245

PolyCycle Innovation Showcases Sustainability at PACK EXPO International PolyCycle Innovation, LLC (PolyCycle) is getting ready to make waves at PACK EXPO International, where it will unveil an array of its innovative post-consumer recycled (PCR) plastic solutions. As more companies pivot towards sustainable packaging, PolyCycle is at the forefront, offering dynamic PCR...

Continue Reading